Material-Specific Roadmap Modes Can Improve the Visibility of Liquid Embolic Agents for Endovascular Embolization: A Systematic In Vitro Study

References

1. 1.↵
   1. Gross BA,
   2. Du R

   . Diagnosis and treatment of vascular malformations of the brain. Curr Treat Options Neurol 2014;16:279 doi:10.1007/s11940-013-0279-9 pmid:24318447

   CrossRefPubMed
2. 2.↵
   1. Friedlander RM

   . Clinical practice: arteriovenous malformations of the brain. N Engl J Med 2007;356:2704–12 doi:10.1056/NEJMcp067192 pmid:17596605

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Chen CJ,
   2. Ding D,
   3. Derdeyn CP, et al

   . Brain arteriovenous malformations: a review of natural history, pathobiology, and interventions. Neurology 2020;95:917–27 doi:10.1212/WNL.0000000000010968 pmid:33004601

   Abstract/FREE Full Text
4. 4.↵
   1. Wu EM,
   2. El Ahmadieh TY,
   3. McDougall CM, et al

   . Embolization of brain arteriovenous malformations with intent to cure: a systematic review. J Neurosurg 2019;132:388–99 doi:10.3171/2018.10.JNS181791 pmid:30717053

   CrossRefPubMed
5. 5.↵
   1. Gross BA,
   2. Albuquerque FC,
   3. Moon K, et al

   . Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas. J Neurosurg 2017;126:1884–93 doi:10.3171/2016.5.JNS16331 pmid:27588586

   CrossRefPubMed
6. 6.↵
   1. Patsalides A,
   2. Knopman J,
   3. Santillan A, et al

   . Endovascular treatment of spinal arteriovenous lesions: beyond the dural fistula. AJNR Am J Neuroradiol 2011;32:798–808 doi:10.3174/ajnr.A2190 pmid:20651018

   Abstract/FREE Full Text
7. 7.↵
   1. Vollherbst DF,
   2. Chapot R,
   3. Bendszus M, et al

   . Glue, Onyx, Squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin Neuroradiol 2022;32:25–38 doi:10.1007/s00062-021-01066-6

   CrossRefPubMed
8. 8.↵
   1. Dehairs M,
   2. Bosmans H,
   3. Marshall NW

   . Implementation of a spatio-temporal figure of merit for new automatic dose rate control regimes in dynamic x-ray imaging. Phys Med Biol 2019;64:045001 doi:10.1088/1361-6560/aafd5c pmid:30630158

   CrossRefPubMed
9. 9.↵
   1. Werncke T,
   2. Kemling M,
   3. Tashenov S, et al

   . Impact of a contrast-to-noise ratio driven and material specific exposure control on image quality and radiation exposure in angiography. Phys Med Biol 2021;66:065020 doi:10.1088/1361-6560/abe83a pmid:33709957

   CrossRefPubMed
10. 10.↵
    1. Schmitt N,
    2. Wucherpfennig L,
    3. Hohenstatt S, et al

    . Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study. J Neurointerv Surg 2022;4:018958 doi:10.1136/neurintsurg-2022-018958 pmid:35508379

    Abstract/FREE Full Text
11. 11.↵
    1. Goode AR,
    2. Snyder C,
    3. Snyder A, et al

    . Signal and contrast to noise ratio evaluation of fluoroscopic loops for interventional fluoroscope quality control. J Appl Clin Med Phys 2019;20:172–80 doi:10.1002/acm2.12734 pmid:31593338

    CrossRefPubMed
12. 12.↵
    1. Altman DG

    . Practical Statistics for Medical Research. CRC Press; 1990
13. 13.↵
    1. Cohen J

    . A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37–46 doi:10.1177/001316446002000104

    CrossRefWeb of Science
14. 14.↵
    1. Derdeyn CP,
    2. Zipfel GJ,
    3. Albuquerque FC, et al

    ; American Heart Association Stroke Council. Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2017;48:e200–24 doi:10.1161/STR.0000000000000134 pmid:28642352

    Abstract/FREE Full Text